ArticleHuman mutation2023

REVEL Is Better at Predicting Pathogenicity of Loss-of-Function than Gain-of-Function Variants.

Jasmin J Hopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.